1. Gardiner F.W., McCuaig R., Arthur C., Carins T., Morton A., Laurie J., et al. The prevalence and pregnancy outcomes of intrahepatic cholestasis of pregnancy: A retrospective clinical audit review. Obstet Med. 2019; 12(3):123–8.
2. Ovadia C., Williamson C. Intrahepatic cholestasis of pregnancy: Recent advances. Clin Dermatol. 2016; 34(3):327–34.
3. Geenes V., Chappell L.C., Seed P.T., Steer P.J., Knight M., Williamson C. Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based case-control study. Hepatology. 2014; 59(4):1482–91.
4. Diken Z., Usta I.M., Nassar A.H. A clinical approach to intrahepatic cholestasis of pregnancy. Am J Perinatol. 2014; 31(1):1–8.
5. Lindor K.D., Lee R.H. Intrahepatic cholestasis of pregnancy. UpToDate. 2019; .
6. Furrer R., Winter K., Schäffer L., Zimmermann R., Burkhardt T., Haslinger C. Postpartum Blood Loss in Women Treated for Intrahepatic Cholestasis of Pregnancy. Obstet Gynecol. 2016; 128(5):1048–52.
7. Bicocca M.J., Sperling J.D., Chauhan S.P. Intrahepatic cholestasis of pregnancy: Review of six national and regional guidelines. Eur J Obstet Gynecol Reprod Biol. 2018; 231:180–7.
8. Wikström Shemer E., Marschall H.U., Ludvigsson J.F., Stephansson O. Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: a 12-year population-based cohort study. BJOG. 2013; 120(6):717–23.
9. TOXNET Databases https://www.nlm.nih.gov/toxnet/index.html. Natl Libr Med. 2017; .
10. Успенская Ю.Б. Современное состояние проблемы холестаза беременных. Проблемы женского здоровья. 2013; 8(3): 70-6.
11. Wood A.M., Livingston E.G., Hughes B.L., Kuller J.A. Intrahepatic Cholestasis of Pregnancy: A Review of Diagnosis and Management. Obstet Gynecol Surv. 2018; 73(2):103–9.
12. Reichert M.C., Lammert F. ABCB4 Gene Aberrations in Human Liver Disease: An Evolving Spectrum. Semin Liver Dis. 2018; 38(4):299–307.
13. Floreani A., Caroli D., Lazzari R., Memmo A., Vidali E., Colavito D., et al. Intrahepatic cholestasis of pregnancy: new insights into its pathogenesis. J Matern Fetal Neonatal Med. 2013; 26(14):1410–5.
14. Dixon P.H., Williamson C. The pathophysiology of intrahepatic cholestasis of pregnancy. Clin Res Hepatol Gastroenterol. 2016; 40(2):141–53.
15. Sticova E., Jirsa M., Pawłowska J. New Insights in Genetic Cholestasis: From Molecular Mechanisms to Clinical Implications. Can J Gastroenterol Hepatol. 2018; 2018:2313675.
16. Ивашкин В.Т., Широкова Е.Н., Маевская М.В., Павлов Ч.С., Шифрин О.С., Маев И.В., et al. Клинические рекомендации Российской гастроэнтерологической ассоциации и Российского общества по изучению печени по диагностике и лечению холестаза. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2015; 25(2):41–57.
17. Reyes H. Sex hormones and bile acids in intrahepatic cholestasis of pregnancy. Hepatology. 2008; 47(2):376–9.
18. Majewska A., Godek B., Bomba-Opon D., Wielgos M. Association between intrahepatic cholestasis in pregnancy and gestational diabetes mellitus. A retrospective analysis. Ginekol Pol. 2019; 90(8):458–63.
19. Gençosmanoğlu Türkmen G., Vural Yilmaz Z., Dağlar K., Kara Ö., Sanhal C.Y., Yücel A., et al. Low serum vitamin D level is associated with intrahepatic cholestasis of pregnancy. J Obstet Gynaecol Res. 2018; 44(9):1712–8.
20. Morton A., Laurie J. The biochemical diagnosis of intrahepatic cholestasis of pregnancy. Obstet Med. 2019; 12(2):76–8.
21. Herrera C.A. Diagnosis and Management of cholestasis. Рregnancy care. ECHO. April 8-th, 2016.
22. Cui D., Zhong Y., Zhang L., Du H. Bile acid levels and risk of adverse perinatal outcomes in intrahepatic cholestasis of pregnancy: A meta-analysis. J Obstet Gynaecol Res. 2017; 43(9):1411–20.
23. Marschall H.-U. Management of intrahepatic cholestasis of pregnancy. Expert Rev Gastroenterol Hepatol. 2015; 9(10):1273–9.
24. Chappell L.C., Bell J.L., Smith A., Linsell L., Juszczak E., Dixon P.H., et al. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial. Lancet (London, England). 2019; 394(10201):849–60.
25. Batsry L., Zloto K., Kalter A., Baum M., Mazaki-Tovi S., Yinon Y. Perinatal outcomes of intrahepatic cholestasis of pregnancy in twin versus singleton pregnancies: is plurality associated with adverse outcomes? Arch Gynecol Obstet. 2019; 300(4):881–7.
26. Zhang Y., Lu L., Victor D.W., Xin Y., Xuan S. Ursodeoxycholic Acid and S-adenosylmethionine for the Treatment of Intrahepatic Cholestasis of Pregnancy: A Meta-analysis. Hepat Mon. 2016; 16(8):e38558.
27. Kroumpouzos G., Cohen L.M. Specific dermatoses of pregnancy: an evidence-based systematic review. Am J Obstet Gynecol. 2003; 188(4):1083–92.
28. Güney E., Uçar T. Effect of the fetal movement count on maternal-fetal attachment. Jpn J Nurs Sci. 2019; 16(1):71–9.
29. Matsubara S., Matsubara D., Takahashi H., Baba Y. Perceived fetal movement count as a traditional but essential tool for evaluating fetal health: some additions and Japanese bstetricians’ and pediatricians’ view. J Matern Fetal Neonatal Med. 2018; 31(2):251–2.
30. Awad N.A., Jordan T., Mundle R., Farine D. Management and Outcome of Reduced Fetal Movements-is Ultrasound Necessary? J Obstet Gynaecol Can. 2018; 40(4):454–9.
31. Flenady V., Ellwood D., Bradford B., Coory M., Middleton P., Gardener G., et al. Beyond the headlines: Fetal movement awareness is an important stillbirth prevention strategy. Women Birth. 2019; 32(1):1–2.
32. Heazell A.E.P., Budd J., Li M., Cronin R., Bradford B., McCowan L.M.E., et al. Alterations in maternally perceived fetal movement and their association with late stillbirth: findings from the Midland and North of England stillbirth case-control study. BMJ Open. 2018; 8(7):e020031.
33. Bryant J., Jamil R.T., Thistle J. Fetal Movement. StatPearls. 2019.
34. Mangesi L., Hofmeyr G.J., Smith V., Smyth R.M.D. Fetal movement counting for assessment of fetal wellbeing. Cochrane database Syst Rev. 2015; 15;(10):CD(10):CD004909.
35. Heazell A.E.P., Weir C.J., Stock S.J.E., Calderwood C.J., Burley S.C., Froen J.F., et al. Can promoting awareness of fetal movements and focusing interventions reduce fetal mortality? A stepped-wedge cluster randomised trial (AFFIRM). BMJ Open. 2017; 7(8):e014813.
36. Norman J.E., Heazell A.E.P., Rodriguez A., Weir C.J., Stock S.J.E., Calderwood C.J., et al. Awareness of fetal movements and care package to reduce fetal mortality (AFFIRM): a stepped wedge, cluster-randomised trial. Lancet (London, England). 2018; 392(10158):1629–38.
37. Ovadia C., Seed P.T., Sklavounos A., Geenes V., Di Ilio C., Chambers J., et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Lancet (London, England). 2019; 393(10174):899–909.